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We measured alveolar NO concentration, bronchial
NO flux, and levels of 8-isoprostane and LTB4 in exhaled
breath condensate (EBC) in 61 subjects with COPD.
These measurements were repeated in 40 patients after
4 weeks of treatment with inhaled fluticasone (500 μg
b.i.d.).
Subjects with COPD had higher levels of 8-iso-
prostane and LTB4 in EBC, increased alveolar NO
concentration, but decreased bronchial NO flux as
compared with healthy subjects. Bronchial NO flux
correlated positively with β2-agonist-induced change in
FEV1 (r=0.372, p=0.003), but other inflammatory
markers were not related to lung function. Baseline
levels of bronchial NO flux were associated with higher
increase in FEV1/FVC (r=0.313, p=0.049) and better
symptom alleviation during the fluticasone treatment.
In conclusion, high bronchial NO flux in COPD predicts
favourable acute response to β2-agonists and a good
response also to treatment with ICS. The other tested
markers are not related to disease severity or treatment
responses in COPD.
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Vascular endothelial growth factor (VEGF) is involved in
lung development, angiogenesis and in response to
injury. Chronic obstructive pulmonary disease (COPD) is
an inflammatory disease characterised by accumulation
of T-cells and remodelling of the airways. We
hypothesized that T-cell secreted VEGF is modulated by
cigarette-smoke and by a hypoxic microenvironment
and that these conditions have an impact on protein
secretion from T-cells from patients with COPD.
T-cells were isolated from peripheral blood of
healthy donors and stimulated in normoxia and hypoxia
with or without exposure to cigarette smoke extract
(CE). VEGF and selected cytokines were measured in
T-cell conditioned media (CBA flex set and ELISA).
Hypoxia (1-2% O2) stimulated VEGF secretion from T-
cells, whereas the release of inflammatory cytokines
(IL-4, IL-6, IL-10, IL-13, IFN-γ and TNF) were not
affected. CE did not influence VEGF secretion neither in
hypoxia nor in normoxia whereas cytokine secretion was
inhibited by CE in both conditions. T-cells from COPD-
patients (FEV1 23-63 % of predicted) secreted
significantly more VEGF compared to T-cells from age-
matched healthy individuals.
The persistent VEGF secretion despite an inhibition
of other T-cell secreted mediators by CE suggests that
VEGF may act as a modulating factor in a hypoxic
microenvironment in COPD. This hypothesis is supported
by elevated VEGF levels from stimulated T-cells from
COPD patients.
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Type I and III collagen protein precursors are increased
in fibrosing processes in the lung. The aim of this study
was to compare the expression of these precursor
proteins in the small airways of nonsmokers, smokers
and COPD-patients with different severity of the
disease, as a marker of newly formed fibrosis.
Procollagen I and III aminoterminal peptides (PINP
and PIIINP) were studied by immunohistochemistry in
lung tissue of 16 life-long non-smokers, 20 current
smokers with normal lung function and 20 current
smokers with COPD. Tissue specimens from tumor-free
peripheral lung tissue were selected. COPD was defined
according to GOLD criteria.
No expression of PINP was found in the subepithelial
layer of small bronchioli. In peripheral bronchioli the
PIIINP expressing layer was thickest in stage I-II COPD
and thinnest in severe COPD (p=0.015). Western blotting
of the total lung homogenates showed a higher level of
PIIINP in nonsmokers compared to smoker groups.
In small airways, PIIINP expression increases in mild-
moderate COPD but decreases at end-state disease, as a
marker of cessation of active fibrogenesis. However, the
total lung homogenate shows decreased expression of
PIIINP in all smoker groups, referring to the possibility of
balance shift towards degradation in other lung
compartments.
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